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Research Round Up- End of Life Care in a Global Pandemic 
Introduction 
The last research round up provided an overview of recent research around prescribing medication 
and symptom management in end of life care. In this month’s review of recent publications we will 
continue to build upon the theme of end of life care by looking at end of life care in a global 
pandemic. Many of you will have experience of caring for people at the end of their life whether that 
be in their home setting, hospice setting or in hospital. Many of the rapid publications in this area 
are commentary or editorial pieces and much new research is to be expected in these areas.  
 
End-of-life decisions and care in the midst of a global coronavirus (COVID-19) pandemic 
This editorial considers how end of life decision making has been impacted by the SARS-COVID-19 
pandemic. They state that the ‘unprecedented and unfolding global has forced health care providers 
globally to consider end-of-life issues in a very rapidly changing scenario. They discuss the need to 
have end of life conversations earlier in chronic illness and the issue of healthcare provider facing 
shortages of beds to care for people t the end of life. The issue of pandemic planning incorporating 
end of life care is also discussed. NCIE guidance is also an area they recommend healthcare 
professionals use to help with decision making. The COVID 19: Rapid Guidance for Critical Care 
(National  Institute of Clinical Health and Excellence (NICE), 2020) published in response to the 
pandemic, places the focus on how and when to use frailty on admission to help inform rapid and 
timely admission decisions. The Association of Palliative Medicine have issued guidance to support 
palliative care clinicians providing palliative care in secondary care. Like many other things in this 
situation these are rapidly produced publications and will no doubt change and evolve as COID-19 
does. Another area addressed is the area of bereavement support and the issue of providing this in 
larger numbers in unexpected situations. There is an expectation that future research and 






End-of-life care in the emergency department for the patient imminently dying of a highly 
transmissible acute respiratory infection (such as COVID-19) 
This commentary piece looks at end of life care in the ED about care of the imminently dying who 
have COVID-19 and state that interventions should be as early as possible in the patients care but 
still being patient centred. The recommendations provided were based on best evidence where 
available and by consensus from ‘Canadian physicians who practice both Emergency and Palliative 
Medicine’.  
The recommendations include 
 Document the discussion around goals of care 
 Consider involving Spiritual Care, Social Work, and/ or Palliative Care if appropriate. 
 Place the patient in a private room if possible 
 Visiting as per local protocols 
 Symptom management 
The article also discusses approached to when and how to withdraw life saving interventions. They 
conclude that as the situation of COVID continues to grow that many end of life discussions may now 








Commentary piece Providing quality end-of-life care to older people in the era of COVID-19: 
perspectives from five countries 
This commentary piece looks at frailty and end of life care in the frail elderly in light of the COVID-19 
pandemic. They sate that ‘Providing quality end-of-life care for older people is one of our biggest 
challenges in this new COVID-19 era’. The authors provide statistics form a range of current sources 
regarding morbidity and mortality in the elderly population due to covid-19 compared with the 
under 45 age group and the figures are quite revealing. They do state that frailty alone is only one 
aspect to consider and that use of an accepted frailty index to assess risk should be used. The article 
also discusses issues around human rights and advanced care planning in this patient population. 
Symptom management is well discussed and as this article draws from 5 different countries the 
issues of assisted dying and euthanasia are touched upon. Long term care, including that in hospice, 
hospital and at home is well attended to.  The article concludes with some suggestions for clinicians 
including 
 How to use guidelines to fatten the curve 
 Embracing change for example tele-medicine and remote consultations as a change to 
working practices. 
 The role of staff and organisational support 







Characteristics, Symptom Management, and Outcomes of 101 Patients With COVID-19 Referred for 
Hospital Palliative Care 
This article sought to identify symptom burden, management, response to treatment, and outcomes 
for a case series of 101 inpatients with confirmed COVID-19 referred to hospital palliative care at 
two large London hospitals. Data was collected from medical and nursing case notes. The most 
prevalent symptoms (n) were breathlessness (67), agitation (43), drowsiness (36), pain (23), and 
delirium (24). The commonest medicines prescribed in the period of study were opioids and 
midazolam. At the end of the study period, 75 patients had died; 13 been discharged back to team, 
home, or hospice; and 13 continued to receive inpatient palliative care. This is discussed as being the 
first report of characteristics, symptom management, and outcomes of patients withCOVID-19 
referred for hospital palliative care. In addition, they reveal that patients near the end of life 
commonly experience agitation, while cough is infrequent. Time spent under the palliative care team 
was brief (median time 2 days), and symptom control with subcutaneous infusion was achieved in 
most cases using relatively small doses of opioid and benzodiazepine. They conclude that patients 
severely affected by COVID-19 frequently experience symptoms and distress, and palliative care is an 








The area of end of life care in a global pandemic presents the prescriber with a wide range of 
challenges, especially considering the recent changes seen due to COVID-19. Prescribers need to be 
aware of guidelines supporting prescribing decision making but also the need to tailor the clinical 
interventions to meet patient’s needs. 
 
